Daniel M. Scott

Chemistry · Physical Sciences

14h-index775citations30works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radical Photochemical Reactions(7), Cell Adhesion Molecules Research(7), Catalytic C–H Functionalization Methods(5), Advanced MRI Techniques and Applications(3), Lanthanide and Transition Metal Complexes(3)

Publications30 total

銅/アゾジカルボキシラート触媒好気性アルコール酸化の機構:非協調触媒作用の立証
Journal of the American Chemical Society·2016· 1 cited
Inhibition of LFA‐1/ICAM Interaction for the Treatment of Autoimmune Diseases
Methods and principles in medicinal chemistry·2013· 2 cited
Understanding the Reaction Mechanism in the Sugar-Air Flow Battery
ECS Meeting Abstracts·2012Open Access
Potential of a Novel Sugar-Air Flow Battery
ECS Meeting Abstracts·2012Open Access
Mechanistic understanding of monosaccharide-air flow battery electrochemistry
Journal of Power Sources·2011· 18 cited
Structure–activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors
Bioorganic & Medicinal Chemistry Letters·2008· 4 citedOpen Access
Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors
Bioorganic & Medicinal Chemistry Letters·2008· 26 citedOpen Access
Dye Mediator-Enzyme Anodes for Application in Biofuel Cells
ECS Meeting Abstracts·2007Open Access
Structural, Kinetic, and Thermodynamic Characterization of the Interconverting Isomers of MS-325, a Gadolinium(III)-Based Magnetic Resonance Angiography Contrast Agent
Inorganic Chemistry·2007· 31 cited
Dye Mediator-Enzyme Anodes for Application in Biofuel Cells
ECS Meeting Abstracts·2007Open Access
Design, Synthesis, and Analysis of a Polyethelene Glycol-Modified (PEGylated) Small Molecule Inhibitor of Integrin α4β1 with Improved Pharmaceutical Properties
Journal of Pharmacology and Experimental Therapeutics·2005· 19 cited
First Synthesis of Piperazine-derived [1,2,4]Triazolo[1,5-a]pyrazine as an Adenosine A2A Receptor Antagonist
Heterocycles·2005· 6 citedOpen Access
Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE
Blood·2003· 78 citedOpen Access
A Small Molecule α4β1/α4β7 Antagonist Differentiates between the Low-Affinity States of α4β1 and α4β7: Characterization of Divalent Cation Dependence
Journal of Pharmacology and Experimental Therapeutics·2003· 9 cited
An Assessment of the Mechanistic Differences Between Two Integrin α4β1 Inhibitors, the Monoclonal Antibody TA-2 and the Small Molecule BIO5192, in Rat Experimental Autoimmune Encephalomyelitis
Journal of Pharmacology and Experimental Therapeutics·2003· 60 cited
The Effect of a Phosphodiester Linking Group on Albumin Binding, Blood Half-Life, and Relaxivity of Intravascular Diethylenetriaminepentaacetato Aquo Gadolinium(III) MRI Contrast Agents
Journal of Medicinal Chemistry·2002· 64 cited
Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding
Journal of Molecular Biology·2000· 125 cited
Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding 1 1Edited by I. A. Wilson
Journal of Molecular Biology·2000· 62 cited
STRUCTURE OF T. GONDII ADENOSINE KINASE BOUND TO PRODRUG 2 7-IODOTUBERCIDIN AND AMP-PCP
1999
STRUCTURE OF T. GONDII ADENOSINE KINASE BOUND TO ADENOSINE
1999
page 1 of 2Next →

Frequent Co-authors

Ned A. Porter(8), Maria A. Schumacher(4), I.I. Mathews(4), S.E. Ealick(4), David S. Roos(4), Mark Cornebise(4), Andrew T. McPhail(4), Randall B. Lauffer(3), Zoltán Tyeklár(3), Katarina S. Midelfort(3), Thomas J. McMurry(3), Cheryl Nickerson‐Nutter(3), Stuart J. Perper(3), Eric T. Whalley(3), Russell C. Petter(3), R. Blake Pepinsky(3), Bernd Giese(3), Kevin M. Guckian(3), Bor Yann Liaw(3), Buddy Ullman(2)